MIRA INFORM REPORT

 

 

Report Date :

20.02.2014

 

IDENTIFICATION DETAILS

 

Name :

NUTRA SPECIALITIES PRIVATE LIMITED (w.e.f. 28.03.2007)

 

 

Formerly Known As :

NEUTRA SPECIALITIES PRIVATE LIMITED

 

 

Registered Office :

No.26, Vandalur-Kelambakkam Main Road, Keelakottaiyur, Chennai – 600048, Tamilnadu

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

15.09.2005

 

 

Com. Reg. No.:

18-057504

 

 

Capital Investment / Paid-up Capital :

Rs. 150.066 Millions

 

 

CIN No.:

[Company Identification No.]

U24231TN2005PTC057504

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CHEN05728C

 

 

PAN No.:

[Permanent Account No.]

AACCN1943Q

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Neutraceuticals, Food Supplements, speciality chemicals and products of similar nature. 

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (12)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

The company has recorded huge accumulated losses.

 

The rating also take into consideration the current delays in debt servcing by the company on account of tight liquidity.

 

However, business is active. Payments terms are reported to be slow.

 

The company can be considered for business dealings on a secured trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – December 1, 2013

 

Country Name

Previous Rating

(30.09.2013)

Current Rating

(01.12.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

The worst is over for India’s economy with gross domestic product likely to expand 5 %to 5.5 % this year and more than 6 % in 2015, according to Moody’s Analytics. Concerns over the rupee and current account deficit are under control, said the agency. Ratings firm Crisil has forecast 6 % growth for 2014/15 up from the estimated 4.8 % for 2013/14.  Total economic growth, infrastructure bottlenecks and lack of transparency and consistency in foreign direct investment policies seem to have taken a toll on India’s attractiveness as an investment destination, says an Ernst & Young survey.  Projects with FDI component fell 16.4 % across the globe in 2012 from the previous year.  The drop in India was steeper at 21 %. State run carrier Air India is doling out free tickets to its 24000 employees, even as it expects to incur a loss of Rs 39000 mn this financial year and has a debt of Rs 350000 mn. 550000 number of jobs generated across India in 2013, a fall of 0.4 % as compared to with a year earlier. The National  Capital Region has a one-fourth share in total jobs created, according to a study by industry lobby group Assochem, Banks, real estate, automobile and telecommunications sectors are showing a rise of job creation. $ 805 mn investments by venture capital firms in India during 2013, registering a drop of about 18 % over the previous year. The Information Technology and IT-Enabled  Services Industry retained its status as the favourable venture capital investors in 2013. Pakistan has temporarily banned gold imports for the second time in six months, as it tries to stem smuggling into India. India’s import duty on gold is 10 % and curbs on purchases have dried up legal imports into what used to be the world’s biggest bullion buyers. The World Gold Council puts the amount smuggled into India at upto 200 tonnes in 2013. The Reserve Bank of India has proposed that unclaimed bank deposits estimated to be about Rs 35000 mn be used for education and awareness among depositors.  According to the plan, deposits that have not been claimed for at least 10 years will be transferred to the scheme.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Term Loan (Long Term): “D”

Rating Explanation

The company is in default or excepted to be in default soon.

Date

June, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Srinivasan

Designation :

General Manager (Finance / Accounts)

Contact No.:

91-44-42984141

Date :

19.02.2014

 

 

LOCATIONS

 

Registered Office :

No.26, Vandalur-Kelambakkam Main Road, Keelakottaiyur, Chennai – 600048, Tamilnadu, India

Tel No.:

Not Available

Fax No.:

Not Available

E-Mail :

suresh.r@lifecellinternational.com

mahesh.d@lifecell.in

Website :

www.nutraforlife.com

 

 

Factory:

Sr. No.69, Chandrapadiya village, Vinjamur Mandal, Nellore District - 524228
Andhra Pradesh, India

Tel No.:

91-8629-214145/ 6

91-8627-300100

Fax No.:

91-8627-300111

 

 

Chennai Office :

No.4, First Floor, Bharathi Nagar, 4th Street, T. Nagar, Chennai – 600017, Tamilnadu, India

Tel No.:

91-44-42984141

Fax No.:

91-44-42121880

E-Mail :

marketing@nutraforlife.com

 

 

US Office:

200, Galleria Parkway Suite 450, Atianta GA 30339, USA

Tel No.:

001 770 916 1722

Fax No.:

001 770 916 1933

 

 

DIRECTORS

 

As on 20.09.2013

 

Name :

Mr. Jayarama Ramanan

Designation :

Director

Address :

C-41, Chaitanya Nest, No.9, Rathna Nagar Main Road, Teyanmpet, Chennai – 600018, Tamilnadu, India

Date of Birth/Age :

02.07.1946

Date of Appointment :

29.09.2011

DIN No. :

00028252

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U85196TN2004PTC053577

LIFECELL INTERNATIONAL PRIVATE LIMITED

Whole-time director

28/06/2004

28/06/2004

-

Active

NO

2

U67120TN1995PTC030953

ABUSHA INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED

Director

08/07/2004

08/07/2004

26/05/2008

Active

NO

3

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Director

29/09/2011

15/09/2005

-

Active

NO

4

U52311TN2005PTC057635

NEUTRA MARKETING PRIVATE LIMITED

Director

27/09/2005

27/09/2005

-

Strike off

NO

5

U85100TN2007PTC063975

TRI CELL THERAPEUTICS PRIVATE LIMITED

Director

15/06/2007

15/06/2007

-

Active

NO

6

U25209TN1996PLC035849

GREEN GOLD POLYMERS LIMITED

Additional director

01/08/2007

01/08/2007

-

Strike off

NO

7

AAB-4427

BRAHMAVIDYA LLP

Designated Partner

04/04/2013

04/04/2013

-

Active

NO

 

 

Name :

Mr. Ramamurthy Thyagarajan

Designation :

Director

Address :

No.12, Besant Road, Royapettah, Chennai – 600014, Tamilnadu, India

Date of Birth/Age :

25.08.1937

Date of Appointment :

30.09.2008

DIN No. :

00185036

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U99999MH1985PTC035149

CREDENTIAL FINANCE LIMITED

Director

20/09/1996

20/09/1996

26/08/2009

Dormant

NO

2

U22219TN1993PLC025407

ECONOMIST COMMUNICATIONS LIMITED

Director

11/06/2002

11/06/2002

-

Active

NO

3

U72200TN2000PTC044605

SHRIRAM CENTRE FOR LEARNING PRIVATE LIMITED

Director

02/01/2003

02/01/2003

20/11/2011

Active

NO

4

U67120TN1995PTC030953

ABUSHA INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED

Director

08/07/2004

08/07/2004

26/05/2008

Active

NO

5

U85196TN2004PTC053577

LIFECELL INTERNATIONAL PRIVATE LIMITED

Director

08/07/2004

08/07/2004

-

Active

NO

6

U65929TN2004NPL053788

CONFEDERATION OF INDIAN NON BANKING FINANCE ENTITIES

Director

21/07/2004

21/07/2004

-

Active

NO

7

U66010AP2005PLC045616

SHRIRAM LIFE INSURANCE COMPANY LIMITED

Director

15/03/2005

15/03/2005

10/12/2009

Active

NO

8

U66010RJ2006PLC029979

SHRIRAM GENERAL INSURANCE COMPANY LIMITED

Director

28/07/2006

28/07/2006

10/11/2009

Active

NO

9

U65991TN2007PLC064133

TVS CAPITAL FUNDS LIMITED

Director

20/08/2008

21/10/2007

-

Amalgamated

NO

10

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Director

30/09/2008

17/11/2007

-

Active

NO

11

U85100TN2007PTC063975

TRI CELL THERAPEUTICS PRIVATE LIMITED

Director

30/09/2008

03/12/2007

-

Active

NO

12

L25209TN1986PLC013098

VICTORY LAMINATIONS LIMITED

Director

01/11/2011

01/11/2011

-

Active

NO

13

U74900TN1995PLC032506

SHRIRAM VENTURE LIMITED

Additional director

04/02/2013

04/02/2013

-

Active

NO

14

U93090TN1996PLC034522

MEDISPAN LIMITED

Additional director

04/10/2013

04/10/2013

-

Active

NO

15

U65191TN1994PLC028851

TVS Capital Funds Limited

Additional director

01/11/2013

01/11/2013

-

Active

NO

 

 

Name :

Mr. Vallavanur Subramaniam Pattabiraman

Designation :

Whole-time director

Address :

No.2-A, Jeypore Palace, 12, Padmavathiar Road, Gopalapuram, Chennai – 600086, Tamilnadu, India

Date of Appointment :

15.09.2005

DIN No. :

00784247

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74210TN2002PTC049065

PRECIMAX TECH PRIVATE LIMITED

Director

10/06/2002

10/06/2002

01/11/2007

Active

YES

2

U85196TN2004PTC053577

LIFECELL INTERNATIONAL PRIVATE LIMITED

Director

28/06/2004

28/06/2004

15/02/2013

Active

NO

3

U67120TN1995PTC030953

ABUSHA INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED

Director

08/07/2004

08/07/2004

26/05/2008

Active

NO

4

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Whole-time director

15/09/2005

15/09/2005

-

Active

NO

5

U52311TN2005PTC057635

NEUTRA MARKETING PRIVATE LIMITED

Director

27/09/2005

27/09/2005

-

Strike off

NO

6

U85100TN2007PTC063975

TRI CELL THERAPEUTICS PRIVATE LIMITED

Director

15/06/2007

15/06/2007

-

Active

NO

7

L21012TN2005PLC092783

SERVALAKSHMI PAPER LIMITED

Director appointed in casual vacancy

09/06/2012

09/06/2012

-

Active

NO

8

AAB-4427

BRAHMAVIDYA LLP

Designated Partner

04/04/2013

04/04/2013

-

Active

NO

 

 

Name :

Mr. Giridhar Gopal Pulleti

Designation :

Director

Address :

Plot No. MIG 41/A, Flat No. 3-2, MCH Park, Beside Vengala Rao Nagar, Hyderabad – 500038, Andhra Pradesh, India

Date of Birth/Age :

10.08.1968

Date of Appointment :

29.09.2011

DIN No. :

01594062

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24232AP2007PTC052453

SANOVA PHARMA CHEM PRIVATE LIMITED

Director

22/01/2007

22/01/2007

-

Active

NO

2

L24230MH2006PLC158589

DR.DATSONS LABS LIMITED

Director

04/05/2010

20/03/2010

-

Active

NO

3

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Director

29/09/2011

21/05/2010

-

Active

NO

4

L65999MH1985PLC035113

FINAVENTURE CAPITAL LIMITED

Director

30/09/2011

20/11/2010

-

Active

NO

5

U24297AP2009PTC064991

CHEMSYNTH LABORATORIES PRIVATE LIMITED

Director

03/01/2011

03/01/2011

03/04/2011

Active

NO

6

U24232AP2012PTC084908

RAICHUR LABORATORIES PRIVATE LIMITED

Director

18/12/2012

18/12/2012

-

Active

NO

7

U24232AP2012PTC085122

ABHUSHA PHARMA PRIVATE LIMITED

Director

31/12/2012

31/12/2012

-

Active

NO

 

 

Name :

Mr. Deepak Abhayakumar

Designation :

Director

Address :

No.27, Mylai Ranganathan Street, T. Nagar, Chennai – 600017, Tamilnadu, India

Date of Birth/Age :

12.04.1983

Date of Appointment :

29.09.2011

DIN No. :

02043654

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U67120TN1995PTC030953

ABUSHA INVESTMENT AND MANAGEMENT SERVICES PRIVATE LIMITED

Director

30/09/2008

26/05/2008

Active

NO

2

U24111TN2000PTC044076

SANSKAR CHEMICALS AND DRUGS PRIVATE LIMITED

Director

02/03/2009

02/03/2009

Active

NO

3

U72900TN2009PTC072512

ENGRID GLOBAL PRIVATE LIMITED

Director

07/08/2009

07/08/2009

Active

NO

4

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Director

29/09/2011

22/11/2010

Active

NO

5

U55101TN2012PTC086654

PURPLETREE HOTELS AND HOSPITALITY SERVICES PRIVATE LIMITED

Director

06/07/2012

06/07/2012

Active

NO

 

 

Name :

Mr. Mohan Reddy Enaganuri

Designation :

Director

Address :

Yerrabellipalem, Vinjamur, Nellore – 524228, Andhra Pradesh, India

Date of Birth/Age :

24.06.1971

Date of Appointment :

29.09.2011

DIN No. :

02720838

Other Directorship :

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24297AP2009PTC064991

CHEMSYNTH LABORATORIES PRIVATE LIMITED

Director

09/09/2009

09/09/2009

Active

NO

2

U24231TN2005PTC057504

NUTRA SPECIALITIES PRIVATE LIMITED

Director

29/09/2011

21/05/2010

Active

NO

3

U24232AP2010PTC069596

HATRI PHARMA PRIVATE LIMITED

Director

21/07/2010

21/07/2010

Active

NO

4

U20296AP2012PTC080563

GREEN GOLD BIO COAL PRIVATE LIMITED

Director

27/04/2012

27/04/2012

Active

NO

5

U24232AP2012PTC085122

ABHUSHA PHARMA PRIVATE LIMITED

Director

31/12/2012

31/12/2012

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Srinivasan

Designation :

General Manager (Finance / Accounts)

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 20.09.2013

 

NOTE: SHAREHOLDING AND ALLOTTEES DETAILS FILE ATTACHED

 

 

As on 20.09.2013

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage of Holding

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

5.59

Bodies corporate

10.41

Directors or relatives of Directors

24.07

Other top fifty shareholders

59.93

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Neutraceuticals, Food Supplements, speciality chemicals and products of similar nature. 

 

 

Products :

Item Code No. (ITC Code)

Product Description

98041000

Bulk Drugs

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Divulged

 

 

Bankers :

Canara Bank, K B Nagar Branch, Adyar, Chennai - 600020, Tamilnadu, India

 

 

Facilities :

SECURED LOANS

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

LONG TERM BORROWINGS

 

 

Rupee term loans from banks

81.505

92.983

Loans and advances from directors

3.557

1.912

SHORT TERM BORROWINGS

 

 

Working capital loans from banks

79.438

60.511

Loans taken for vehicles

2.031

0.692

Total

166.531

156.098

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Srikanth and Shanthi

Chartered Accountants

Address :

No.9 Madanagopal Street, First Floor, Abhiramapuram, Chennai – 600018, Tamilnadu, India

Income-tax PAN of auditor or auditor's firm :

AAOFS4951L

 

 

CAPITAL STRUCTURE

 

After 20.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20,000,000

Equity Shares

Rs.10/- each

Rs. 200.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20,000,000

Equity Shares

Rs.10/- each

Rs. 200.000 Millions

 

 

 

 

 

 

As on 31.03.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

20,000,000

Equity Shares

Rs.10/- each

Rs. 200.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

15,006,588

Equity Shares

Rs.10/- each

Rs. 150.066 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

150.066

143.066

143.066

(b) Reserves & Surplus

(106.195)

(90.838)

(72.518)

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

10.901

7.001

0.001

Total Shareholders’ Funds (1) + (2)

54.772

59.229

70.549

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

85.062

94.894

84.161

(b) Deferred tax liabilities (Net)

9.116

8.977

7.671

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

94.178

103.871

91.832

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

245.254

159.204

91.180

(b) Trade payables

67.791

83.402

43.690

(c) Other current liabilities

2.811

2.538

0.886

(d) Short-term provisions

4.214

3.334

2.049

Total Current Liabilities (4)

320.070

248.478

137.805

 

 

 

 

TOTAL

469.020

411.578

300.186

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

164.616

174.146

142.130

(ii) Intangible Assets

7.594

5.163

7.604

(iii) Capital work-in-progress

52.142

21.471

31.632

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

3.220

1.776

0.983

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

227.572

202.556

182.349

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

100.163

97.043

59.809

(c) Trade receivables

104.281

86.881

48.729

(d) Cash and cash equivalents

16.320

11.437

4.165

(e) Short-term loans and advances

13.182

10.204

3.533

(f) Other current assets

7.502

3.457

1.601

Total Current Assets

241.448

209.022

117.837

 

 

 

 

TOTAL

469.020

411.578

300.186

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

TOTAL                                    

365.983

257.545

162.228

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

TOTAL                                    

358.064

253.987

175.191

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION                          

7.919

3.558

(12.963)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                    

23.137

20.573

15.755

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX 

(15.218)

(17.015)

(28.718)

 

 

 

 

 

Less

TAX                                                                 

0.139

1.305

1.769

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX

(15.357)

(18.320)

(30.487)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

211.300

NA

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

(1.02)

(1.28)

(21.13)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

(4.20)

(7.11)

(18.79)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(3.65)

(4.36)

(10.69)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.28)

(0.29)

(0.41)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

6.03

4.29

2.49

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.75

0.84

0.86

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

143.066

143.066

150.066

Reserves & Surplus

(72.518)

(90.838)

(106.195)

Share Application money pending allotment

0.001

7.001

10.901

Net worth

70.549

59.229

54.772

 

 

 

 

long-term borrowings

84.161

94.894

85.062

Short term borrowings

91.180

159.204

245.254

Total borrowings

175.341

254.098

330.316

Debt/Equity ratio

2.485

4.290

6.031

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

162.228

257.545

365.983

 

 

58.755

42.104

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Total Income

162.228

257.545

365.983

Profit

(30.487)

(18.320)

(15.357)

 

(18.79%)

(7.11%)

(4.20%)

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

INDEX OF CHARGES

 

S.NO.

CHARGE ID

DATE OF CHARGE CREATION/MODIFICATION

CHARGE AMOUNT SECURED

CHARGE HOLDER

ADDRESS

SERVICE REQUEST NUMBER (SRN)

1

10474878

06/12/2013

727,000.00

CANARA BANK

K B NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

B95204111

2

10194767

30/12/2009

500,000.00

CANARA BANK

KASTURBA NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

A76842558

3

10164698

23/06/2009

280,000.00

CANARA BANK

KASTURBA NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

A64970148

4

10119914

31/07/2008

1,063,000.00

CANARA BANK

KASTURBA NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

A44532745

5

10031254

13/12/2006

880,000.00

CANARA BANK

K.B.NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

A08714859

6

10025741

11/11/2006

549,000.00

CANARA BANK

K.B.NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

A06653190

7

10025505

03/08/2011 *

245,100,000.00

CANARA BANK

KASTURBA NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

B19435684

8

10025740

26/08/2013 *

363,943,000.00

CANARA BANK

KASTURBA NAGAR BRANCH, ADYAR, CHENNAI - 600020, TAMILNADU, INDIA

B87190922

 

* Date of charge modification

 

 

UNSECURED LOANS

 

PARTICULAR

31.03.2013

(Rs. In Millions)

31.03.2012

(Rs. In Millions)

SHORT TERM BORROWINGS

 

 

Other loans and advances, others

163.785

98.000

Total

163.785

98.000

 

 

HIGHLIGHTS OF FINANCIAL POSITION AND PROSPECTS:

 

1. The Income from Operations/ Sales have been growing steadily: Rs. 87.000 Millions in 2010, Rs 160.100 Millions in 2011, Rs 253.500 Millions in 2012 and Rs 347.800 Millions in 2013.

 

2. The Company has made significant additions to its Product mix by stabilizing in the process in the production of new major products such as Sitagliptin Phosphate, Moxifloxacin in addition to Olmesatan and others.

 

3. The Export has been growing; Rs 11.400 Millions in 2010, Rs 74.200 Millions in 2011, Rs 178.000 Millions in 2012 and 211.400 Millions in 2013.

 

4. The company is earning Royalty income for its product Levetiracetam without affecting its production capacity.

 

 

COMPANY’S OUTLOOK FOR FUTURE:

 

Maintaining the current trend, the company expects to substantially increase the turnover to nearly two folds in the current year and is confident of reaching Profit after depreciation in the Financial year 2013-14. However it may take some time to make up for the past losses. Continuous efforts are being made to introduce, produce and stabilize the process of making additional products while at the same time optimizing the gap with adequate quality measures.

 

 

FIXED ASSETS

 

v  Tangible Assets

·         Land

·         Buildings

·         Plant and Equipment

·         Furniture and Fixtures

·         Vehicles

·         Motor Vehicles

·         Office Equipment

·         Computer Equipments

·         Other Equipments

 

v  Intangible assets

·         Copyrights, Patents and Other Operating Rights

·         Other Intellectual Property Rights

 

 


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.62.12

UK Pound

1

Rs.103.93

Euro

1

Rs.85.17

 

 

INFORMATION DETAILS

 

Information Gathered by :

PDT

 

 

Report Prepared by :

MRI

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

--

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

2

--RESERVES

1~10

--

--CREDIT LINES

1~10

--

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

12

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)12

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.